Prostate Cancer Clinical Trial

Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

Summary

This study will evaluate the proportion of prostate cancer patients receiving external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT) with controlled blood sugars (fasting glucose and hemoglobin A1c), blood pressure, and cholesterol profile (total cholesterol, LDL, HDL, triglycerides) at baseline, 3 months, and 12 months after completing radiation treatment. In addition, receipt of guideline-recommended cardiovascular, primary and preventive care as well as patient-reported quality of life and satisfaction with care among these patients will be evaluated at baseline and 12 months.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histologically-confirmed, non-metastatic prostate cancer
Patients who will receive external beam radiation treatment with androgen deprivation therapy (total ADT duration > 3 months) for curative treatment, either in the definitive or post-prostatectomy setting
Patients who have a primary care provider
Informed consent obtained and signed
Ability to read and write English
Age >= 18
No mental incompetence which would preclude completion of questionnaires

Exclusion Criteria:

Prior cancer, pelvic radiation treatment or chemotherapy
Patients who do not have a primary care provider
Prior ADT
Mental incompetence which would preclude completion of questionnaires
Unable to read and write English

Study is for people with:

Prostate Cancer

Estimated Enrollment:

101

Study ID:

NCT02003417

Recruitment Status:

Completed

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 8 Locations for this study

See Locations Near You

Medstar Georgetown University Hospital
Washington District of Columbia, 20007, United States
University of North Carolina at Chapel Hill Cancer Hospital
Chapel Hill North Carolina, 27599, United States
High Point Regional UNC Health Care
High Point North Carolina, 27262, United States
Rex Healthcare, Inc
Raleigh North Carolina, 27607, United States
Rex Healthcare of Wakefield
Raleigh North Carolina, 27614, United States
Marion L. Shepard Cancer Center
Washington North Carolina, 27889, United States
Coastal Carolina Radiation Oncology
Wilmington North Carolina, 28401, United States
University of Virginia
Charlottesville Virginia, 22908, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

101

Study ID:

NCT02003417

Recruitment Status:

Completed

Sponsor:


UNC Lineberger Comprehensive Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider